Literature DB >> 21550339

Extracellular ATP through P2 receptors activates AMP-activated protein kinase and suppresses superoxide generation in cultured mouse podocytes.

Agnieszka Piwkowska1, Dorota Rogacka, Maciej Jankowski, Stefan Angielski.   

Abstract

Podocytes are an important constituent of the glomerular filtration barrier. The function of these glomerular cells is affected by extracellular nucleotides through P2 receptors. The activation of P2 receptors may lead to the activation of NAD(P)H oxidase, the key enzyme in oxidative stress, with the intracellular pathways leading to intracellular ATP depletion associated with an increase in the intracellular AMP:ATP ratio. This deregulation of the energy balance activates AMP-activated protein kinase (AMPK) to restore energy homeostasis. We investigated whether P2 receptor activation influences NAD(P)H oxidase-dependent rate of superoxide anion (O(2)(•-)) generation and AMPK activity in cultured mouse podocytes. The rate of O(2)(•-) generation was measured by chemiluminescence and changes in AMPK activity were determined by immunoblotting against AMPKα-Thr(172)-P. The addition of 100 μM ATP induced a rapid and transient decrease in rate of O(2)(•-) generation and increased AMPK phosphorylation with maximal effects in the first minute (2.44±0.09 versus 1.62±0.06 nmol/mg protein/min, P<0.05 and 0.64±0.04 versus 0.97±0.07, P<0.05, respectively). Both parameters returned to control levels at 10 min. Suramin (300 μM, P2 receptor antagonist) and compound C (100μM, AMPK inhibitor) completely, and STO-609 (25 μM, CaMKK-β inhibitor) partially, prevented ATP action in rate of O(2)(•-) generation and AMPK phosphorylation. Various ATP analogues (10 μM) mimicked the effects of ATP on rate of O(2)(•-) generation and AMPK phosphorylation. The data indicate that extracellular ATP, acting through P2 receptors upstream of CaMKK-β, modulates podocyte function through simultaneous effects on AMPK and NAD(P)H oxidase activities. This mechanism may play a role in restoring energy homeostasis after oxidative stress.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550339     DOI: 10.1016/j.yexcr.2011.04.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

Review 1.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

2.  Chloride secretion by renal collecting ducts.

Authors:  Madhumitha Rajagopal; Darren P Wallace
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-09       Impact factor: 2.894

3.  Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease.

Authors:  Joseph Satriano; Kumar Sharma; Roland C Blantz; Aihua Deng
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-03

Review 4.  Extracellular Nucleotides and P2 Receptors in Renal Function.

Authors:  Volker Vallon; Robert Unwin; Edward W Inscho; Jens Leipziger; Bellamkonda K Kishore
Journal:  Physiol Rev       Date:  2019-08-22       Impact factor: 37.312

5.  Pharmacological characterization of the P2 receptors profile in the podocytes of the freshly isolated rat glomeruli.

Authors:  Daria V Ilatovskaya; Oleg Palygin; Vladislav Levchenko; Alexander Staruschenko
Journal:  Am J Physiol Cell Physiol       Date:  2013-09-18       Impact factor: 4.249

Review 6.  Functional and therapeutic importance of purinergic signaling in polycystic kidney disease.

Authors:  Daria V Ilatovskaya; Oleg Palygin; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2016-09-21

7.  AMPK Suppresses Connexin43 Expression in the Bladder and Ameliorates Voiding Dysfunction in Cyclophosphamide-induced Mouse Cystitis.

Authors:  Xiling Zhang; Jian Yao; Kun Gao; Yuan Chi; Takahiko Mitsui; Tatsuya Ihara; Norifumi Sawada; Manabu Kamiyama; Jianglin Fan; Masayuki Takeda
Journal:  Sci Rep       Date:  2016-01-25       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.